EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nuclear medicine and perspective thoughts in the diagnosis and treatment of pheochromocytoma and paraganglioma

Emirhan Harbi iD, Michael Aschner

Journal of Neuroendocrinology · 2025-08 · 37 (8)

DOI: 10.1111/jne.70017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 05.03.2025. Verfasst von Emirhan Harbi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA. Hauptthemen laut MEDLINE: Pheochromocytoma, Adrenal Gland Neoplasms, Paraganglioma, Nuclear Medicine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 185 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pheochromocytoma and paraganglioma (PPGL) are rare and life‐threatening tumors of the adrenal medulla and extra‐adrenal paraganglia, respectively. Management of PPGL depends on accurate diagnosis and treatment. This review provides a very comprehensive overview of nuclear medicine in PPGL with some of our perspective views on diagnostic challenges and pitfalls, treatment, and new phase studies. It describes nuclear medicine techniques including 64 Cu/ 68 Ga‐DOTA‐SSA, 18 F‐FDOPA, 18 F‐FDG, 123 I‐MIBG, and some emerging molecular imaging agents and PRRT therapies, such as 203 Pb VMT‐α‐NET and 212 Pb VMT‐α‐NET targeted alpha therapy (TAT). It also provides insight into the use of proliferating cell nuclear antigen (PCNA) inhibitors in combination with therapeutics in aggressive/metastatic PPGL. Through a comprehensive review of the latest developments and clinical practice, this review aims to guide healthcare professionals in improving the diagnostic accuracy and therapeutic efficacy of PPGL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaAdrenal Gland NeoplasmsParagangliomaNuclear MedicineHumansRadiopharmaceuticals

Stichwörter der Autor:innen

diagnosis and treatmentnuclear medicineparagangliomapheochromocytoma

Substanzen

Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA.

ORCID-Profile: Emirhan Harbi

Zitieren

APA

Harbi, E., & Aschner, M. (2025). Nuclear medicine and perspective thoughts in the diagnosis and treatment of pheochromocytoma and paraganglioma. Journal of Neuroendocrinology, 37(8). https://doi.org/10.1111/jne.70017

Vancouver

Harbi E, Aschner M. Nuclear medicine and perspective thoughts in the diagnosis and treatment of pheochromocytoma and paraganglioma. Journal of Neuroendocrinology. 2025;37(8). doi:10.1111/jne.70017

BibTeX
@article{Harbi2025,
  author = {Harbi, Emirhan and Aschner, Michael},
  title = {Nuclear medicine and perspective thoughts in the diagnosis and treatment of pheochromocytoma and paraganglioma},
  journal = {Journal of Neuroendocrinology},
  year = {2025},
  volume = {37},
  number = {8},
  doi = {10.1111/jne.70017}
}
Kostenlos starten →